Tg Therapeutics reported $2.03M in Sales Revenues for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Sales Change
Abbvie ABBV:US $ 14342M 383M
Acceleron Pharma XLRN:US $ 34.2M 6.26M
Amgen AMGN:US $ 6706M 180M
Ardelyx ARDX:US $ 1.17M 0.14M
Arena Pharmaceuticals ARNA:US $ 0M 0M
Arrowhead Research ARWR:US $ 38.28M 7.61M
Bayer BAYN:GR € 9781M 1073M
Biogen BIIB:US $ 2778.9M 3.9M
Corcept Therapeutics CORT:US $ 96.13M 4.54M
Curis CRIS:US $ 3.04M 0.75M
Dynavax Technologies DVAX:US $ 108.27M 55.5M
Gilead Sciences GILD:US $ 7421M 1204M
Infinity Pharmaceuticals INFI:US $ 0.43M 0.08M
Intercept Pharmaceuticals ICPT:US $ 92.83M 3.75M
Johnson & Johnson JNJ:US $ 23338M 26M
Karyopharm Therapeutics KPTI:US $ 37.69M 15.09M
Novartis NOVN:VX SF 13367M 73M
Novavax NVAX:US $ 178.84M 119.17M
Ptc Therapeutics PTCT:US $ 138.74M 22.07M
Puma Biotechnology PBYI:US $ 46.24M 7.14M
Regeneron Pharmaceuticals REGN:US $ 3452.8M 1685.7M
Tg Therapeutics TGTX:US $ 2.03M 0.48M
Verastem VSTM:US $ 0M 0.5M
Vertex Pharmaceuticals VRTX:US $ 1984.16M 190.79M